InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,987.37
(
0.30%
)
US TECH 100
20,184.40
(
-0.23%
)
Dow Jones
44,736.57
(
0.99%
)
Brent Oil
72.62
(
0.01%
)
Bitcoin
94,116.56
(
1.11%
)
Post# of 3535
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Report Keyboard Shortcuts
Prev Next

go seek

Send PM Follow Ignore
Followers 21
Posts 4892
Boards Moderated 0
Alias Born 06/24/2006

go seek

Member Level

Re: None

Tuesday, 11/26/2024 12:05:58 AM

Tuesday, November 26, 2024 12:05:58 AM

Post# of 3535
>> Would Dr. Luly continue to illuminate the possibility of two leading candidates for RSV, knowing the RSVPEDS trial fell short of expectations? I don’t think so…

(Dr. Luly today) “With results from our RSVPEDs study of zelicapavir, our RSV N-inhibitor, expected in December, we could potentially have two of the leading clinical candidates for the treatment of RSV with different mechanisms of action, providing us with important optionality.“
Bullish
Bullish

The creation of a thousand forests is in one acorn.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Report Keyboard Shortcuts
Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ENTA News
More ENTA News
InvestorsHub NewsWire

FoodTech Trailblazer Beyond Oil Appoints New COO from KFC Amidst Massive Global Expansion (OTCQB: BEOLF) (CSE: BOIL), up 250% this year • BOIL • Nov 25, 2024 11:12 AM

UC Asset announces plan of acquisition to increase awareness for its stock trading • UCASU • Nov 25, 2024 9:30 AM

HealthLynked Receives $500,000 Payment Milestone from Sale of ACO Health Partners • HLYK • Nov 25, 2024 8:00 AM

Critical Metals Surge Opens Prime Opportunity for Mining Investors • PLG • Nov 22, 2024 8:30 AM

ILUS Agrees to Swap Majority Stake in Quality Industrial Corp. for Future Majority Stake in Fusion Fuel Green (NASDAQ: HTOO) • ILUS • Nov 20, 2024 9:07 AM

Avant Technologies and Ainnova Advancing Proprietary Retinal Camera to Market with Vision AI Software • AVAI • Nov 20, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!